Use of a diagonal approach to health system strengthening and measles elimination after a large nationwide outbreak in Mongolia

Emerging Infectious Diseases

Volumn 23, Issue , 2017, Pages S77-S84

  Hagan, José E ^a   Greiner, Ashley ^a   Luvsansharav, Ulzii Orshikh ^a   Lake, Jason ^a   Lee, Christopher ^a   Pastore, Roberta ^b   Takashima, Yoshihiro ^b   Sarankhuu, Amarzaya ^c   Demberelsuren, Sodbayar ^b   Smith, Rachel ^a   Park, Benjamin ^a   Goodson, James L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Ministry of Health and Sports   (Mongolia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNICABLE DISEASE; DISEASE CLEARANCE; DISEASE SURVEILLANCE; HEALTH CARE; HEALTH CARE FACILITY; HUMAN; MEASLES; MONGOLIA; NONHUMAN; POST EXPOSURE PROPHYLAXIS; TREATMENT RESPONSE; VACCINATION; DISEASE ERADICATION; EMERGENCY; EPIDEMIC; HEALTH SURVEY; HISTORY; OUTCOME ASSESSMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; SEASON;

MEASLES VACCINE;

DISEASE ERADICATION; DISEASE OUTBREAKS; EMERGENCIES; HISTORY, 21ST CENTURY; HUMANS; IMMUNIZATION PROGRAMS; MEASLES; MEASLES VACCINE; MONGOLIA; OUTCOME ASSESSMENT (HEALTH CARE); PUBLIC HEALTH SURVEILLANCE; SEASONS; VACCINATION;

EID: 85040996925     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2313.170594     Document Type: Article

References (47)

1. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016;2:16049. http://dx.doi.org/10.1038/nrdp.2016.49
2. Centers for Disease Control (CDC). Measles outbreak among vaccinated high school students—Illinois. MMWR Morb Mortal Wkly Rep. 1984;33:349–51.
3. Güris D, Harpaz R, Redd SB, Smith NJ, Papania MJ. Measles surveillance in the United States: an overview. J Infect Dis. 2004;189(Suppl 1):S177–84. http://dx.doi.org/10.1086/374606
4. Orenstein WA, Halsey NA, Hayden GF, Eddins DL, Conrad JL, Witte JJ, et al. From the Center for Disease Control: current status of measles in the United States, 1973–1977. J Infect Dis. 1978;137:847–53. http://dx.doi.org/10.1093/infdis/137.6.847
5. Landrigan PJ. Epidemic measles in a divided city. JAMA. 1972;221:567–70. http://dx.doi.org/10.1001/jama.1972.03200190013003
6. Goodson JL, Seward JF. Measles 50 years after use of measles vaccine. Infect Dis Clin North Am. 2015;29:725–43. http://dx.doi.org/10.1016/j.idc.2015.08.001
7. Parker AA, Staggs W, Dayan GH, Ortega-Sánchez IR, Rota PA, Lowe L, et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med. 2006;355:447–55. http://dx.doi.org/10.1056/NEJMoa060775
8. Andrus JK, Cochi SL, Cooper LZ, Klein JD. Combining global elimination of measles and rubella with strengthening of health systems in developing countries. Health Aff (Millwood). 2016;35:327–33. http://dx.doi.org/10.1377/hlthaff.2015.1005
9. Orenstein WA, Seib K. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination. Expert Rev Vaccines. 2016;15:791–3. http://dx.doi.org/10.1586/14760584.2016.1165614
10. World Health Organization. Global Vaccine Action Plan 2011–2020. Geneva: The Organization; 2011 [cited 2017 Mar 1]. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
11. World Health Organization. Global measles and rubella strategic plan 2012–2020. Geneva: The Organization; 2012 [cited 2017 Mar 1]. http://www.who.int/immunization/documents/control/ISBN_978_92_4_150339_6/en/
12. Chan M, Elias C, Fauci A, Lake A, Berkley S. Reaching everyone, everywhere with life-saving vaccines. Lancet. 2017;389:777–9. http://dx.doi.org/10.1016/S0140-6736(17)30554-8
13. World Health Organization. International Health Regulations (2005). 2nd ed. [cited 2017 Mar 1]. http://whqlibdoc.who.int_publications_2008_9789241580410_eng.pdf
14. Frieden TR, Tappero JW, Dowell SF, Hien NT, Guillaume FD, Aceng JR. Safer countries through global health security. Lancet. 2014;383:764–6. http://dx.doi.org/10.1016/S0140-6736(14)60189-6
15. Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele J-M, et al. Progress toward regional measles elimination—worldwide, 2000–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1228–33. http://dx.doi.org/10.15585/mmwr.mm6544a6
16. Global Health Security Agenda. Membership [cited 2017 Jan 1]. https://www.GHSAgenda.org/members
17. World Health Organization. Outbreak surveillance and response in humanitarian emergencies: WHO guidelines for EWARN implementation. Geneva: The Organization; 2012.
18. World Health Organization. Guidelines on verification of measles elimination in the Western Pacific Region. Geneva: The Organization; 2013.
19. Hagan JE, Takashima Y, Sarankhuu A, Dashpagma O, Jantsansengee B, Pastore R, et al. Risk factors for measles virus infection among adults during a large outbreak in postelimination era in Mongolia, 2015. J Infect Dis. 2017. In press.
20. Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial transmission of measles: an updated review. Vaccine. 2012; 30:3996–4001. http://dx.doi.org/10.1016/j.vaccine.2012.04.023
21. Biellik RJ, Clements CJ. Strategies for minimizing nosocomial measles transmission. Bull World Health Organ. 1997;75:367–75.
22. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(RR-7):1–45.
23. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(Suppl 2):S65–164. http://dx.doi.org/10.1016/j.ajic.2007.10.007
24. World Health Organization Regional Office for Western Pacific and Regional Office for South-East Asia. Practical guidelines for infection control in health care facilities. 2004 [cited 2017 Mar 1]. http://www.wpro.who.int/publications/docs/practical_guidelines_infection_control.pdf
25. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-04):1–34.
26. Mongolia Ministry of Health and Sports. National standard on measles surveillance [in Mongolian]. Ulaanbaatar (Mongolia): The Ministry; 2003.
27. World Health Organization Regional Office for the Western Pacific. Field guidelines for measles elimination. 2004 [cited 2016 Jan 4]. http://www.wpro.who.int/publications/docs/FieldGuidelines_for_MeaslesElimination_0F24.pdf
28. World Health Organization. Framework for a public health Emergency Operations Center. Geneva: The Organization; 2015 [cited 2017 Mar 1]. http://www.who.int/ihr/publications/9789241565134_eng/en/
29. World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, November 2013—conclusions and recommendations. Wkly Epidemiol Rec. 2014;89:1–20.
30. Choi WS, Sniadack DH, Jee Y, Go UY, So JS, Cho H, et al. Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission. J Infect Dis. 2011;204(Suppl 1):S483–90. http://dx.doi.org/10.1093/infdis/jir087
31. Marshall TM, Hlatswayo D, Schoub B. Nosocomial outbreaks—a potential threat to the elimination of measles? J Infect Dis. 2003;187(Suppl 1):S97–101. http://dx.doi.org/10.1086/368041
32. Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial transmission of measles: an updated review. Vaccine. 2012; 30:3996–4001. http://dx.doi.org/10.1016/j.vaccine.2012.04.023
33. Pillsbury A, Chiew M, Bag S, Hope K, Norton S, Conaty S, et al. The changing epidemiology of measles in an era of elimination: lessons from health-care-setting transmissions of measles during an outbreak in New South Wales, Australia, 2012. Western Pac Surveill Response J. 2016;7:12–20. http://dx.doi.org/10.5365/wpsar.2016.7.1.010
34. Goodson JL, Sosler S, Pasi O, Johnson T, Kobella M, Monono ME, et al. Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009. J Infect Dis. 2011;204(Suppl 1):S252–9. http://dx.doi.org/10.1093/infdis/jir151
35. Goodson JL, Wiesen E, Perry RT, Mach O, Kitambi M, Kibona M, et al. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania. Vaccine. 2009;27:5870–4. http://dx.doi.org/10.1016/j.vaccine.2009.07.057
36. Wolicki SB, Nuzzo JB, Blazes DL, Pitts DL, Iskander JK, Tappero JW. Public health surveillance: at the core of the Global Health Security Agenda. Health Secur. 2016;14:185–8. http://dx.doi.org/10.1089/hs.2016.0002
37. Balajee SA, Arthur R, Mounts AW. Global Health Security: building capacities for early event detection, epidemiologic workforce, and laboratory response. Health Secur. 2016;14:424–32. http://dx.doi.org/10.1089/hs.2015.0062
38. Grais RF, Conlan AJ, Ferrari MJ, Djibo A, Le Menach A, Bjørnstad ON, et al. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008;5:67–74. http://dx.doi.org/10.1098/rsif.2007.1038
39. World Health Organization. Measles vaccines: WHO position paper. Wkly Epidemiol Rec. 2009;84:349–60.
40. Moss JL, Reiter PL, Truong YK, Rimer BK, Brewer NT. School entry requirements and coverage of nontargeted adolescent vaccines. Pediatrics. 2016;138:e20161414. http://dx.doi.org/10.1542/peds.2016-1414
41. Centers for Disease Control and Prevention (CDC). Elimination of measles—South Korea, 2001–2006. MMWR Morb Mortal Wkly Rep. 2007;56:304–7.
42. Orenstein WA, Hinman AR. The immunization system in the United States—the role of school immunization laws. Vaccine. 1999;17(Suppl 3):S19–24. http://dx.doi.org/10.1016/S0264-410X(99)00290-X
43. Zuo S, Cairns L, Hutin Y, Liang X, Tong Y, Zhu Q, et al. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003–2009. Vaccine. 2015;33:2050–5. http://dx.doi.org/10.1016/j.vaccine.2015.02.078
44. World Health Organization. School immunization programme in Sri Lanka 26 May–2 June 2008. Geneva: The Organization; 2009 [cited 2017 Mar 1]. http://www.who.int/immunization/programmes_systems/policies_strategies/SriLanka-school-immunization.pdf
45. Vaz RG, Mkanda P, Banda R, Komkech W, Ekundare-Famiyesin OO, Onyibe R, et al. The role of the polio program infrastructure in response to Ebola virus disease outbreak in Nigeria 2014. J Infect Dis. 2016;213(Suppl 3):S140–6. http://dx.doi.org/10.1093/infdis/jiv581
46. Mulders MN, Rota PA, Icenogle JP, Brown KE, Takeda M, Rey GJ, et al. Global Measles and Rubella Laboratory Network support for elimination goals, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:438–42. http://dx.doi.org/10.15585/mmwr.mm6517a3
47. Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in low- and middle-income countries, 2011–20. Health Aff (Millwood). 2016;35:199–207. http://dx.doi.org/10.1377/hlthaff.2015.1086